References
- Aragona E, Kelly MJ. Hyperhemolysis in sickle cell disease. J Pediatr Hematol Oncol 2014;36:54–56.
- Win N. Hyperhemolysis syndrome in sickle cell disease. Expert Rev Hematol 2009;2:111–115.
- Lakmali-Morawakage R, Perera BC, Dias PN, et al. Hyperhemolysis in a patient with β-thalassemia major. Asian J Transf Sci 2009;3:26–27.
- Darabi K, Dzik S. Hyperhemolysis syndrome in anemia of chronic disease. Transfusion 2005;45:1930–1933.
- Treleaven JG, Win N. Hyperhaemolysis syndrome in a patient with myelofibrosis. Hematology 2004;9:147–149.
- Win N, Madan B, Gale R, et al. Intravenous immunoglobulin given to lymphoma patients with recurrent haemolytic transfusion reactions after transfusion of compatible blood. Hematology 2005;10:375–378.
- Babb A, Diamantos N, Sekhar M. Hyperhaemolysis syndrome treated with corticosteroids and darbopoietin in a patient with mantle cell lymphoma. Transfus Medicine 2012;22:142–144.
- Delmonte L, Cantini M, Oliveri O, et al. Immunoglobulin-resistant delayed hemolytic transfusion reaction treated with rituximab in an adult sickle cell patient. Transfusion 2013;53:688–689.
- Schwartz RS, Tanaka Y, Fidler IJ, et al. Increased adherence of sickled and phosphatidylserine-enriched human erythrocytes to culture human peripheral blood monocytes. J Clin Invest 1985;75:1965–1972.
- Reid ME, Lomas-Francis C, Olsson ML. Rh blood group system. In: Reid ME, Lomas-Francis C, Olsson ML, editors. The blood group antigens factsbook. 3rd ed. London: Elsevier; 2012. pp 147–262.
- Figueroa D. The Diego blood group system: a review. Immuno-hematology 2013;29:73–81.